Publication Highlights
december 2021
infection & immunobiology
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in MS
October 2021
infection & immunobiology
COVID-19 vaccine response in people with multiple sclerosis
Summer 2021
Immunogenicity
Immunogenicity of biologics used in the treatment of moderate to severe psoriasis
summer 2021
immunogenicity
Immunogenicity of biologics used in the treatment of inflammatory bowel disease: A review
summer 2021
immunotherapy failure
Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis
june 2020
Neurology & Neuroscience
Detecting and predicting neutralization of Alemtuzumab responses in Multiple Sclerosis.
may 2020
infection & immunoBIOLOGY
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic